DOCSLIB.ORG

JBC Keywords List

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
JBC Keywords List JBC Keywords List 14‐3‐3 protein 2,3‐butanediol 3‐chlorotyrosine 5‐hydroxymethylcytosine (5‐hmC) 5‐methylcytosine 7‐helix ligand‐gated channel 7‐helix receptor 70 kilodalton heat shock protein (Hsp70) 7SK snRNP 8‐Oxoguanine (8‐oxoG) 8‐Oxoguanine glycosylase (OGG1) A‐kinase anchoring protein (AKAP) ABC transporter ABL tyrosine kinase abscisic acid (ABA) acetoacetate acetyl coenzyme A (acetyl‐CoA) acetyl‐CoA synthetase acetylation acetylcholinesterase (AChE) acetyltransferase acid sensing ion channel (ASIC) acidosis actin actinobacteria activin activin A receptor, type I (ACVR1) acyl carrier protein (ACP) acyltransferase ADAM ADAMTS ADAMTS13 adaptor protein addiction adenosine adenosine receptor adenosylcobalamin (AdoCbl) adenovirus adenylate cyclase (adenylyl cyclase) adenylate kinase (ADK) adenylate‐uridylate‐rich element (AU‐rich element, ARE) adherens junction adhesin adhesion adipocyte adipogenesis adipokine adiponectin adipose tissue adipose tissue metabolism adipose triglyceride lipase (ATGL) ADP ADP ribosylation factor (ARF) ADP‐ribosylation adrenal adrenergic receptor aggrecan (cartilage‐specific proteoglycan core protein (CSPCP)) aggregation aggresome aging AIDS Akt PKB albumin alcohol alcohol dehydrogenase (ADH) aldosterone algae alginate lyase alkB allergen allergy allosteric regulation alpha‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionic acid receptor (AMPA receptor, AMPAR) alpha‐catenin (α‐catenin) alpha‐synuclein (α‐synuclein) alphavirus ALT cell alternative splicing Alzheimer disease amination amino acid amino acid transport aminoacyl tRNA synthetase aminopeptidase ammonia AMP AMP‐activated kinase (AMPK) amyloid amyloid precursor protein (APP) amyloid‐beta (Aβ) amyotrophic lateral sclerosis (ALS) (Lou Gehrig disease) anaerobic glycolysis analytical chemistry analytical ultracentrifugation anandamide (N‐arachidonoylethanolamine) (AEA) anaplerosis androgen androgen receptor anesthesia anesthetic angiogenesis angiotensin angiotensin II animal model animal virus anion transport ankryin annexin anoikis anthrax toxin antibiotic action antibiotic resistance antibiotics antibody antibody engineering anticancer drug anticodon antigen antigen presentation antigen processing antimicrobial peptide (AMP) antioxidant antisense RNA antithrombin (AT) antiviral agent AP1 transcription factor (AP‐1) apolipoprotein apolipoprotein E (ApoE) apolipoprotein gene apoptosis apoptosis signal‐regulating kinase 1 (ASK1) aptamer aquaporin aquaporin 4 (AQP4) Arabidopsis Arabidopsis thaliana arachidonic acid (AA) (ARA) archaea arginine finger Argonaute Arp2/3 complex arrestin arthritis articular cartilage aryl hydrocarbon receptor (AhR) (AHR) ascorbic acid aspartate (aspartic acid) aspartic protease Aspergillus asthma astrocyte ataxia ataxia telangiectasia atherosclerosis atomic force microscopy (AFM) ATP ATP synthase ATP‐binding cassette transporter sub‐family C member 8 (ABCC8) ATP‐dependent protease ATPase ATPases associated with diverse cellular activities (AAA) AU‐rich element RNA‐binding protein 1 (AUF1) autism autoimmune disease autoimmunity autophagy autophagy‐related protein 7 (ATG7) autophosphorylation auxin axin axon B‐cell lymphoma 2 (Bcl‐2) B‐cell lymphoma 2 (Bcl‐2) family Bacillus bacteria bacterial adhesion bacterial conjugation bacterial genetics bacterial intein‐like domain (BIL) bacterial metabolism bacterial pathogenesis bacterial protein kinase bacterial protein phosphatase bacterial signal transduction bacterial toxin bacterial transcription bacteriocin bacteriophage basal lamina base excision repair (BER) basement membrane basic helix‐loop‐helix transcription factor (bHLH) Bax Beclin‐1 (BECN1) beta cell (β‐cell) beta‐catenin (β‐catenin ) beta‐galactoside alpha‐2,6‐sialyltransferase 1 (ST6GAL1) beta‐oxidation beta‐secretase 1 (BACE1) bicarbonate Bifidobacterium bifidum biglycan bile acid biodegradation bioenergetics bioenergy bioengineering biofilm biofuel bioinformatics bioluminescence bioluminescence resonance energy transfer (BRET) biomarker biomaterials biomineralization biophysics biosensor biostatistics biosynthesis biotechnology biotin blood Bombyx mori bone bone marrow bone morphogenetic protein (BMP) Bordetella pertussis botulinum toxin BPC brain brain metabolism brain tumor brain‐derived neurotrophic factor (BDNF) BRCA1 BRCA2 breast cancer bromodomain‐containing protein 4 (BRD4) C‐C chemokine receptor type 5 (CCR5) c‐Fos c‐Jun N‐terminal kinase (JNK) c‐Jun transcription factor C‐terminal domain (carboxyl tail domain, CTD) C‐X‐C chemokine receptor type 4 (CXCR‐4) C1Q complex (C1QA) Ca2+/calmodulin‐dependent protein kinase (CaMK) Ca2+/calmodulin‐dependent protein kinase II (CaMKII) cadherin cadherin‐1 (CDH1) (epithelial cadherin) (E‐cadherin) Caenorhabditis elegans (C. elegans) calcification calcineurin calcium calcium ATPase calcium channel calcium imaging calcium intracellular release calcium release‐activated calcium channel protein 1 (ORAI1) calcium transport calcium‐binding protein calmodulin (CaM) calorimetry calpain cAMP response element‐binding protein (CREB) Campylobacter Campylobacter lari cancer cancer biology cancer chemoprevention cancer prevention cancer stem cells cancer therapy Candida albicans cannabinoid cannabinoid receptor cannabinoid receptor type 1 (CB1) carbohydrate carbohydrate biosynthesis carbohydrate chemistry carbohydrate function carbohydrate metabolism carbohydrate processing carbohydrate structure carbohydrate‐binding protein carbon dioxide carbon fixation carbon monoxide carboxylesterase carboxypeptidase carboxysome carcinogenesis cardiac development cardiac hypertrophy cardiac metabolism cardiac muscle cardiolipin cardiomyocyte cardiomyopathy cardiovascular cardiovascular disease carotenoid cartilage cartilage biology Cas6 caspase caspase 1 (CASP1) catalase catalysis cataract catecholamine catenin cathepsin B (CTSB) caveolae caveolin CBLB CCAAT‐enhancer‐binding protein (C/EBP) CD38 CD44 CD95 (APO‐1/Fas) CDC34 CDC42 cell adhesion cell biology cell compartmentalization cell culture cell cycle cell death cell differentiation cell division cell division cycle 7‐related protein kinase (Cdc7) cell growth cell invasion cell junction cell metabolism cell migration cell motility cell permeabilization cell polarity cell proliferation cell signaling cell sorting cell surface cell surface enzyme cell surface protein cell surface receptor cell therapy cell wall cell‐cell interaction cell‐penetrating peptide (CPP) cellobiohydrolase cellular immune response cellular regulation cellular senescence cellulase cellulose cellulosome central nervous system (CNS) centriole centromere centrosome ceramide ceramide synthase cerebellum cerebral cavernous malformation channel activation chaperone chaperone DnaJ (DnaJ) chaperone DnaK (DnaK) chaperonin Charcot‐Marie‐Tooth disease (CMT) checkpoint control chemical biology chemical modification chemokine chemoprevention chemoresistance chemotaxis Chikungunya virus ChIP‐sequencing (ChIP‐seq) chitin chitinase Chlamydia Chlamydia trachomatis Chlamydomonas chloride channel chloride transport chlorophyll chloroplast cholera toxin cholesterol cholesterol metabolism cholesterol regulation cholesterol‐binding protein choline cholinergic receptor chondrocyte chondrogenesis chondroitin chondroitin sulfate chromatin chromatin immunoprecipitation (ChiP) chromatin modification chromatin regulation chromatin remodeling chromatin structure chromatography chromosomes chronic myelogenous leukemia (CML) chronic obstructive pulmonary disease (COPD) chymotrypsin chymotrypsin C cigarette smoke cilia circadian circadian clock circadian rhythm circular dichroism (CD) clamp loader clathrin click chemistry clock gene cloning Clostridium cellulolyticum cluster of differentiation 4 (CD4) coagulation factor coenzyme A (CoA) coenzyme Q10 (CoQ10) cofilin colicin M colitis collagen collectin colon cancer colorectal cancer complement complement system complex Complex I computation computational biology computer modeling conductance confocal microscopy conformational change connective tissue connective tissue growth factor (CTGF) connexin connexon (hemichannel) contractile protein convertase cooperativity COPI COPII copper copper monooxygenase copper transport cornea cortactin craniofacial development CRISPR/Cas crRNA cryo‐electron microscopy cryptochrome crystal structure crystallin crystallography cyanobacteria cyclic ADP Ribose (cADPR) cyclic AMP (cAMP) cyclic di‐GMP (c‐di‐GMP) cyclic diadenosine monophosphate (c‐di‐AMP) cyclic GMP (cGMP) cyclic nucleotide cyclic peptide cyclin cyclin D1 cyclin‐dependent kinase (CDK) cyclin‐dependent kinase 7 (CDK7) cyclooxygenase (COX) cyclophilin cyclophilin D cyclotide Cys‐loop receptor cysteine protease cysteine‐mediated cross‐linking cystic fibrosis cystic fibrosis transmembrane conductance regulator (CFTR) cytidine deaminase cytochrome cytochrome c cytochrome c oxidase (Complex IV) cytochrome oxidase cytochrome P450 cytokine cytokine action cytokine induction cytokinesis cytoskeleton DDIT4 death domain decarboxylase decorin defensin dehydrogenase deleted in bladder cancer 1 (DBC1) deleted in liver cancer 1 (DLC1) dematin dendrite dendritic cell dendritic spine dengue virus (DENV) dentin deoxyribonuclease (DNase) depression dermatan sulfate desmin desmoglein desmosome deubiquitylation (deubiquitination) development developmental factor diabetes diabetic nephropathy diacylglycerol diacylglycerol kinase (DGK, DAGK) Dicer Dictyostelium diet differentiation dihydropyridine receptor (DHPR) dimerization dioxin dioxygenase directed evolution disulfide DNA
Load more

Recommended publications
  • 要約) Doctoral Dissertation Antibiotics Shapes Population-Level Diversity In
    ) Doctoral Dissertation Antibiotics shapes population-level diversity in the human gut microbiome ( ) Nishijima Suguru Acknowledgments I would like to express my sincere gratitude to my supervisor, Prof. Masahira Hattori, whose expertise, knowledge and continuous encouragement throughout my research. My sincere thanks also go to Assoc. Prof. Kenshiro Oshima (The University of Tokyo), Dr. Wataru Suda and Dr. Seok-Won Kim for their motivation, immense support and encouragement throughout my work. I am also grateful to all my collaborators, Prof. Hidetoshi Morita (Okayama University) for his fecal sample collection, DNA isolation and sincere encouragement, Prof. Kenya Honda and Dr. Koji Atarashi (Keio University) for mice experiments, Assoc. Prof. Masahiro Umezaki (the University of Tokyo) for support for dietary data analysis, Dr. Todd D. Taylor (RIKEN) for support for writing manuscript and Dr. Yuu Hirose (Toyohashi University of technology) for DNA sequencing. I also would like to thank all past and present members of our laboratory, Erica Iioka, Misa Takagi, Emi Omori, Hiromi Kuroyamagi, Naoko Yamashita, Keiko Komiya, Rina Kurokawa, Chie Shindo, Yukiko Takayama and Yasue Hattori for their great technical support and kind assistance. i Antibiotics shapes population-level diversity in the human gut microbiome () Abstract The human gut microbiome has profound influences on the host’s physiology through its interference with various intestinal functions. The development of next-generation sequencing (NGS) technologies enabled us to comprehensively explore ecological and functional features of the gut microbiomes. Recent studies using the NGS-based metagenomic approaches have suggested high ecological diversity of the microbiome across countries. However, little is known about the structure and feature of the Japanese gut microbiome, and the factor that shapes the population-level diversity in the human gut microbiome.
    [Show full text]
  • Hypoxia and Oxygen-Sensing Signaling in Gene Regulation and Cancer Progression
    International Journal of Molecular Sciences Review Hypoxia and Oxygen-Sensing Signaling in Gene Regulation and Cancer Progression Guang Yang, Rachel Shi and Qing Zhang * Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA; [email protected] (G.Y.); [email protected] (R.S.) * Correspondence: [email protected]; Tel.: +1-214-645-4671 Received: 6 October 2020; Accepted: 29 October 2020; Published: 31 October 2020 Abstract: Oxygen homeostasis regulation is the most fundamental cellular process for adjusting physiological oxygen variations, and its irregularity leads to various human diseases, including cancer. Hypoxia is closely associated with cancer development, and hypoxia/oxygen-sensing signaling plays critical roles in the modulation of cancer progression. The key molecules of the hypoxia/oxygen-sensing signaling include the transcriptional regulator hypoxia-inducible factor (HIF) which widely controls oxygen responsive genes, the central members of the 2-oxoglutarate (2-OG)-dependent dioxygenases, such as prolyl hydroxylase (PHD or EglN), and an E3 ubiquitin ligase component for HIF degeneration called von Hippel–Lindau (encoding protein pVHL). In this review, we summarize the current knowledge about the canonical hypoxia signaling, HIF transcription factors, and pVHL. In addition, the role of 2-OG-dependent enzymes, such as DNA/RNA-modifying enzymes, JmjC domain-containing enzymes, and prolyl hydroxylases, in gene regulation of cancer progression, is specifically reviewed. We also discuss the therapeutic advancement of targeting hypoxia and oxygen sensing pathways in cancer. Keywords: hypoxia; PHDs; TETs; JmjCs; HIFs 1. Introduction Molecular oxygen serves as a co-factor in many biochemical processes and is fundamental for aerobic organisms to maintain intracellular ATP levels [1,2].
    [Show full text]
  • Distinct RNA N-Demethylation Pathways Catalyzed by Nonheme Iron ALKBH5 and FTO Enzymes Enable Regulation of Formaldehyde Release Rates
    Distinct RNA N-demethylation pathways catalyzed by nonheme iron ALKBH5 and FTO enzymes enable regulation of formaldehyde release rates Joel D. W. Toha,1, Steven W. M. Crossleya,1, Kevin J. Bruemmera, Eva J. Gea, Dan Hea, Diana A. Iovana, and Christopher J. Changa,b,2 aDepartment of Chemistry, University of California, Berkeley, CA 94720; and bDepartment of Molecular and Cell Biology, University of California, Berkeley, CA 94720 Edited by Amy C. Rosenzweig, Northwestern University, Evanston, IL, and approved August 24, 2020 (received for review April 17, 2020) The AlkB family of nonheme Fe(II)/2-oxoglutarate–dependent oxy- m6A (23) is relatively stable compared to other hydroxymethyl- genases are essential regulators of RNA epigenetics by serving as containing nucleobases and has been reported to decay to the free erasers of one-carbon marks on RNA with release of formaldehyde adenosine (A) base over 10 h (22). m6A is the most prominent (FA). Two major human AlkB family members, FTO and ALKBH5, modification of messenger RNA (mRNA) (24, 25) and is installed by both act as oxidative demethylases of N6-methyladenosine (m6A) the S-adenosylmethionine–dependent METTL3/14-WTAP writer but furnish different major products, N6-hydroxymethyladenosine complex (26) and removed by two human AlkB eraser enzymes, fat (hm6A) and adenosine (A), respectively. Here we identify founda- mass and obesity-associated protein (FTO) (4) and AlkB family tional mechanistic differences between FTO and ALKBH5 that pro- member 5 (ALKBH5) (27). Internal m6A modifications control the mote these distinct biochemical outcomes. In contrast to FTO, fate of mRNA (28–32) through translation, splicing, localization, which follows a traditional oxidative N-demethylation pathway stability, and decay and are connected to cancer progression, im- to catalyze conversion of m6A to hm6A with subsequent slow mune responses, and metabolic states (27, 29, 32–36).
    [Show full text]
  • Potential for and Distribution of Enzymatic Biodegradation of Polystyrene by Environmental Microorganisms
    materials Communication Potential for and Distribution of Enzymatic Biodegradation of Polystyrene by Environmental Microorganisms Liyuan Hou and Erica L.-W. Majumder * Department of Chemistry, SUNY College of Environmental Science and Forestry, Syracuse, NY 13210, USA; [email protected] * Correspondence: [email protected] or [email protected]; Tel.: +1-3154706854 Abstract: Polystyrene (PS) is one of the main polymer types of plastic wastes and is known to be resistant to biodegradation, resulting in PS waste persistence in the environment. Although previous studies have reported that some microorganisms can degrade PS, enzymes and mechanisms of microorganism PS biodegradation are still unknown. In this study, we summarized microbial species that have been identified to degrade PS. By screening the available genome information of microorganisms that have been reported to degrade PS for enzymes with functional potential to depolymerize PS, we predicted target PS-degrading enzymes. We found that cytochrome P4500s, alkane hydroxylases and monooxygenases ranked as the top potential enzyme classes that can degrade PS since they can break C–C bonds. Ring-hydroxylating dioxygenases may be able to break the side-chain of PS and oxidize the aromatic ring compounds generated from the decomposition of PS. These target enzymes were distributed in Proteobacteria, Actinobacteria, Bacteroidetes, and Firmicutes, suggesting a broad potential for PS biodegradation in various earth environments and microbiomes. Our results provide insight into the enzymatic degradation of PS and suggestions for realizing the biodegradation of this recalcitrant plastic. Citation: Hou, L.; Majumder, E.L. Keywords: plastics; polystyrene biodegradation; enzymatic biodegradation; monooxygenase; alkane Potential for and Distribution of hydroxylase; cytochrome P450 Enzymatic Biodegradation of Polystyrene by Environmental Microorganisms.
    [Show full text]
  • Chymotrypsin-Like Peptidases in Insects
    Chymotrypsin-like peptidases in insects Dissertation zur Erlangung des akademischen Grades Doctor rerum naturalium (Dr. rer. nat.) Fachbereich Biologie/Chemie der Universität Osnabrück vorgelegt von Gunnar Bröhan Osnabrück, Mai 2010 TABLE OF CONTENTS I Table of contents 1. Introduction 1 1.1. Serine endopeptidases 1 1.2. The structure of S1A chymotrypsin-like peptidases 2 1.3. Catalytic mechanism of chymotrypsin-like peptidases 6 1.4. Insect chymotrypsin-like peptidases 9 1.4.1. Chymotrypsin-like peptidases in insect immunity 9 1.4.2. Role of chymotrypsin-like peptidases in digestion 14 1.4.3. Involvement of chymotrypsin-like peptidases in molt 16 1.5. Objective of the work 18 2. Material and Methods 20 2.1. Material 20 2.1.1. Culture Media 20 2.1.2. Insects 20 2.2. Molecular biological methods 20 2.2.1. Tissue preparations for total RNA isolation 20 2.2.2. Total RNA isolation 21 2.2.3. Reverse transcription 21 2.2.4. Quantification of nucleic acids 21 2.2.5. Chemical competent Escherichia coli 21 2.2.6. Ligation and transformation in E. coli 21 2.2.7. Preparation of plasmid DNA 22 2.2.8. Restriction enzyme digestion of DNA 22 2.2.9. DNA gel-electrophoresis and DNA isolation 22 2.2.10. Polymerase-chain-reaction based methods 23 2.2.10.1. RACE-PCR 23 2.2.10.2. Quantitative Realtime PCR 23 2.2.10.3. Megaprimer PCR 24 2.2.11. Cloning of insect CTLPs 25 2.2.12. Syntheses of Digoxigenin-labeled DNA and RNA probes 26 2.2.13.
    [Show full text]
  • Concentration of Tissue Angiotensin II Increases with Severity of Experimental Pancreatitis
    MOLECULAR MEDICINE REPORTS 8: 335-338, 2013 Concentration of tissue angiotensin II increases with severity of experimental pancreatitis HIROYUKI FURUKAWA1, ATSUSHI SHINMURA1, HIDEHIRO TAJIMA1, TOMOYA TSUKADA1, SHIN-ICHI NAKANUMA1, KOICHI OKAMOTO1, SEISHO SAKAI1, ISAMU MAKINO1, KEISHI NAKAMURA1, HIRONORI HAYASHI1, KATSUNOBU OYAMA1, MASAFUMI INOKUCHI1, HISATOSHI NAKAGAWARA1, TOMOHARU MIYASHITA1, HIDETO FUJITA1, HIROYUKI TAKAMURA1, ITASU NINOMIYA1; HIROHISA KITAGAWA1, SACHIO FUSHIDA1, TAKASHI FUJIMURA1, TETSUO OHTA1, TOMOHIKO WAKAYAMA2 and SHOICHI ISEKI2 1Department of Gastroenterological Surgery, Division of Cancer Medicine; 2Department of Histology and Embryology, Graduate School of Medical Science, Kanazawa University, Kanazawa, Ishikawa 920-8641, Japan Received January 23, 2013; Accepted May 30, 2013 DOI: 10.3892/mmr.2013.1509 Abstract. Necrotizing pancreatitis is a serious condition that Introduction is associated with high morbidity and mortality. Although vasospasm is reportedly involved in necrotizing pancreatitis, Acute pancreatitis, particularly the necrotizing type, is the underlying mechanism is not completely clear. In addition, associated with high morbidity and mortality. Necrotizing the local renin-angiotensin system has been hypothesized to pancreatitis is characterized by parenchymal non-enhance- be involved in the progression of pancreatitis and trypsin has ment on contrast-enhanced computed tomography images (1). been shown to generate angiotensin II under weakly acidic Although necrosis is irreversible, certain patients exhibiting conditions. However, to the best of our knowledge, no studies this pancreatic parenchymal non-enhancement recover have reported elevated angiotensin II levels in tissue with with normal pancreatic conditions (2). Vasospasm has been pancreatitis. In the present study, the concentration of pancre- implicated in the development of pancreatic ischemia and atic angiotensin II in rats with experimentally induced acute necrosis (3); however, the precise underlying mechanism is pancreatitis was measured.
    [Show full text]
  • Natural Single-Nucleotide Deletion in Chymotrypsinogen C Gene Increases Severity of Secretagogue-Induced Pancreatitis in C57BL/6 Mice
    Natural single-nucleotide deletion in chymotrypsinogen C gene increases severity of secretagogue-induced pancreatitis in C57BL/6 mice Andrea Geisz, … , Eszter Hegyi, Miklós Sahin-Tóth JCI Insight. 2019;4(14):e129717. https://doi.org/10.1172/jci.insight.129717. Research Article Gastroenterology Inflammation Genetic susceptibility to chronic pancreatitis in humans is frequently associated with mutations that increase activation of the digestive protease trypsin. Intrapancreatic trypsin activation is an early event in experimental acute pancreatitis in rodents, suggesting that trypsin is a key driver of pathology. In contrast with trypsin, the pancreatic protease chymotrypsin serves a protective function by mitigating trypsin activation through degradation. In humans, loss-of-function mutations in chymotrypsin C (CTRC) are common risk factors for chronic pancreatitis; however, the pathogenic effect of CTRC deficiency has not been corroborated in animal models yet. Here we report that C57BL/6 mice that are widely used for genetic manipulations do not express functional CTRC because of a single-nucleotide deletion in exon 2 of the Ctrc gene. We restored a functional Ctrc locus in C57BL/6N mice and demonstrated that in the Ctrc+ strain, the severity of cerulein- induced experimental acute and chronic pancreatitis was significantly ameliorated. Improved disease parameters were associated with reduced intrapancreatic trypsin activation, suggesting a causal link between CTRC-mediated trypsinogen degradation and protection against pancreatitis.
    [Show full text]
  • 343747488.Pdf
    Washington University School of Medicine Digital Commons@Becker Open Access Publications 6-1-2020 Systematic validation of variants of unknown significance in APP, PSEN1 and PSEN2 Simon Hsu Anna A Pimenova Kimberly Hayes Juan A Villa Matthew J Rosene See next page for additional authors Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs Authors Simon Hsu, Anna A Pimenova, Kimberly Hayes, Juan A Villa, Matthew J Rosene, Madhavi Jere, Alison M Goate, and Celeste M Karch Neurobiology of Disease 139 (2020) 104817 Contents lists available at ScienceDirect Neurobiology of Disease journal homepage: www.elsevier.com/locate/ynbdi Systematic validation of variants of unknown significance in APP, PSEN1 T and PSEN2 Simon Hsua, Anna A. Pimenovab, Kimberly Hayesa, Juan A. Villaa, Matthew J. Rosenea, ⁎ Madhavi Jerea, Alison M. Goateb, Celeste M. Karcha, a Department of Psychiatry, Washington University School of Medicine, 425 S Euclid Avenue, St Louis, MO 63110, USA b Department of Neuroscience, Mount Sinai School of Medicine, New York, NY, USA ARTICLE INFO ABSTRACT Keywords: Alzheimer's disease (AD) is a neurodegenerative disease that is clinically characterized by progressive cognitive APP decline. More than 200 pathogenic mutations have been identified in amyloid-β precursor protein (APP), presenilin PSEN1 1 (PSEN1) and presenilin 2 (PSEN2). Additionally, common and rare variants occur within APP, PSEN1, and PSEN2 PSEN2 that may be risk factors, protective factors, or benign, non-pathogenic polymorphisms. Yet, to date, no Alzheimer's disease single study has carefully examined the effect of all of the variants of unknown significance reported in APP, Cell-based assays PSEN1 and PSEN2 on Aβ isoform levels in vitro.
    [Show full text]
  • Genetic Testing for Familial Alzheimer's Disease
    Corporate Medical Policy Genetic Testing for Familial Alzheimer’s Disease AHS – M2038 File Name: genetic_testing_for_familial_alzheimers_disease Origination: 1/2019 Last CAP Review: 10/2020 Next CAP Review: 10/2021 Last Review: 10/2020 Description of Procedure or Service Alzheimer disease (AD) is a neurodegenerative disease defined by a gradual decline in memory, cognitive functions, gross atrophy of the brain, and an accumulation of extracellular amyloid plaques and intracellular neurofibrillary tangles (Karch, Cruchaga, & Goate, 2014). Familial Alzheimer disease (FAD) is a rare, inherited form of AD. FAD has a much earlier onset than other forms of Alzheimer disease with symptoms developing in individuals in their thirties or forties. Related Policies General Genetic Testing, Germline Disorders AHS – M2145 General Genetic Testing, Somatic Disorders AHS – M2146 ***Note: This Medical Policy is complex and technical. For questions concerning the technical language and/or specific clinical indications for its use, please consult your physician. Policy BCBSNC will provide coverage for genetic testing for familial Alzheimer disease when it is determined the medical criteria or reimbursement guidelines below are met. Benefits Application This medical policy relates only to the services or supplies described herein. Please refer to the Member's Benefit Booklet for availability of benefits. Member's benefits may vary according to benefit design; therefore member benefit language should be reviewed before applying the terms of this medical policy.
    [Show full text]
  • Harnessing the Power of Bacteria in Advancing Cancer Treatment
    International Journal of Molecular Sciences Review Microbes as Medicines: Harnessing the Power of Bacteria in Advancing Cancer Treatment Shruti S. Sawant, Suyash M. Patil, Vivek Gupta and Nitesh K. Kunda * Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John’s University, Jamaica, NY 11439, USA; [email protected] (S.S.S.); [email protected] (S.M.P.); [email protected] (V.G.) * Correspondence: [email protected]; Tel.: +1-718-990-1632 Received: 20 September 2020; Accepted: 11 October 2020; Published: 14 October 2020 Abstract: Conventional anti-cancer therapy involves the use of chemical chemotherapeutics and radiation and are often non-specific in action. The development of drug resistance and the inability of the drug to penetrate the tumor cells has been a major pitfall in current treatment. This has led to the investigation of alternative anti-tumor therapeutics possessing greater specificity and efficacy. There is a significant interest in exploring the use of microbes as potential anti-cancer medicines. The inherent tropism of the bacteria for hypoxic tumor environment and its ability to be genetically engineered as a vector for gene and drug therapy has led to the development of bacteria as a potential weapon against cancer. In this review, we will introduce bacterial anti-cancer therapy with an emphasis on the various mechanisms involved in tumor targeting and tumor suppression. The bacteriotherapy approaches in conjunction with the conventional cancer therapy can be effective in designing novel cancer therapies. We focus on the current progress achieved in bacterial cancer therapies that show potential in advancing existing cancer treatment options and help attain positive clinical outcomes with minimal systemic side-effects.
    [Show full text]
  • Effects of Glycosylation on the Enzymatic Activity and Mechanisms of Proteases
    International Journal of Molecular Sciences Review Effects of Glycosylation on the Enzymatic Activity and Mechanisms of Proteases Peter Goettig Structural Biology Group, Faculty of Molecular Biology, University of Salzburg, Billrothstrasse 11, 5020 Salzburg, Austria; [email protected]; Tel.: +43-662-8044-7283; Fax: +43-662-8044-7209 Academic Editor: Cheorl-Ho Kim Received: 30 July 2016; Accepted: 10 November 2016; Published: 25 November 2016 Abstract: Posttranslational modifications are an important feature of most proteases in higher organisms, such as the conversion of inactive zymogens into active proteases. To date, little information is available on the role of glycosylation and functional implications for secreted proteases. Besides a stabilizing effect and protection against proteolysis, several proteases show a significant influence of glycosylation on the catalytic activity. Glycans can alter the substrate recognition, the specificity and binding affinity, as well as the turnover rates. However, there is currently no known general pattern, since glycosylation can have both stimulating and inhibiting effects on activity. Thus, a comparative analysis of individual cases with sufficient enzyme kinetic and structural data is a first approach to describe mechanistic principles that govern the effects of glycosylation on the function of proteases. The understanding of glycan functions becomes highly significant in proteomic and glycomic studies, which demonstrated that cancer-associated proteases, such as kallikrein-related peptidase 3, exhibit strongly altered glycosylation patterns in pathological cases. Such findings can contribute to a variety of future biomedical applications. Keywords: secreted protease; sequon; N-glycosylation; O-glycosylation; core glycan; enzyme kinetics; substrate recognition; flexible loops; Michaelis constant; turnover number 1.
    [Show full text]
  • Yeast Genome Gazetteer P35-65
    gazetteer Metabolism 35 tRNA modification mitochondrial transport amino-acid metabolism other tRNA-transcription activities vesicular transport (Golgi network, etc.) nitrogen and sulphur metabolism mRNA synthesis peroxisomal transport nucleotide metabolism mRNA processing (splicing) vacuolar transport phosphate metabolism mRNA processing (5’-end, 3’-end processing extracellular transport carbohydrate metabolism and mRNA degradation) cellular import lipid, fatty-acid and sterol metabolism other mRNA-transcription activities other intracellular-transport activities biosynthesis of vitamins, cofactors and RNA transport prosthetic groups other transcription activities Cellular organization and biogenesis 54 ionic homeostasis organization and biogenesis of cell wall and Protein synthesis 48 plasma membrane Energy 40 ribosomal proteins organization and biogenesis of glycolysis translation (initiation,elongation and cytoskeleton gluconeogenesis termination) organization and biogenesis of endoplasmic pentose-phosphate pathway translational control reticulum and Golgi tricarboxylic-acid pathway tRNA synthetases organization and biogenesis of chromosome respiration other protein-synthesis activities structure fermentation mitochondrial organization and biogenesis metabolism of energy reserves (glycogen Protein destination 49 peroxisomal organization and biogenesis and trehalose) protein folding and stabilization endosomal organization and biogenesis other energy-generation activities protein targeting, sorting and translocation vacuolar and lysosomal
    [Show full text]